21.02.2023 - 23.02.2023Hilton Boston Logan Airport, One Hotel Drive, 02128 Boston, Massachusetts, USA
Time: 09:00 to 17:00
Temi della conferenza With numerous novel conjugate companies recently receiving their INDs to enter the clinic including Avidity Biosciences and Dyne Therapeutics and many more following closely in their footsteps, conjugate drugs comprising of novel payloads and targeting formats are being thrust centre stage within the bioconjugate world.
Speakers: Christian Marsolais, Senior Vice President and Chief Medical Officer, Theratechnologies Inc., Fu-An Kang, Vice President, Research, MiRecule Inc., and more